BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32057158)

  • 1. Risk of second primary cancer in oral squamous cell carcinoma.
    Mroueh R; Nevala A; Haapaniemi A; Pitkäniemi J; Salo T; Mäkitie AA
    Head Neck; 2020 Aug; 42(8):1848-1858. PubMed ID: 32057158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.
    Nikkilä R; Hirvonen E; Haapaniemi A; Tapiovaara L; Pitkäniemi J; Malila N; Mäkitie A
    Acta Oncol; 2023 Oct; 62(10):1322-1330. PubMed ID: 37672344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary cancer following primary oral squamous cell carcinoma: a population-based, retrospective study.
    Petersen LØ; Jensen JS; Jakobsen KK; Grønhøj C; Wessel I; von Buchwald C
    Acta Oncol; 2022 Aug; 61(8):916-921. PubMed ID: 35621254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second primary tumours after squamous cell carcinoma of the oral cavity.
    Brands MT; Campschroer G; Merkx MAW; Verbeek ALM; van Dijk BAC; Geurts SME
    Eur J Surg Oncol; 2021 Aug; 47(8):1934-1939. PubMed ID: 33896667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
    Chuang SC; Scelo G; Tonita JM; Tamaro S; Jonasson JG; Kliewer EV; Hemminki K; Weiderpass E; Pukkala E; Tracey E; Friis S; Pompe-Kirn V; Brewster DH; Martos C; Chia KS; Boffetta P; Brennan P; Hashibe M
    Int J Cancer; 2008 Nov; 123(10):2390-6. PubMed ID: 18729183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide study on cancer recurrences, second primary tumours, distant metastases and survival after treatment for primary head and neck cancer in the Netherlands.
    van de Weerd C; van Dijk BAC; Merkx MAW; Takes RP; Brands MT
    Eur J Surg Oncol; 2023 Jul; 49(7):1154-1161. PubMed ID: 36964057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.
    Lee KD; Lu CH; Chen PT; Chan CH; Lin JT; Huang CE; Chen CC; Chen MC
    BMC Cancer; 2009 Oct; 9():373. PubMed ID: 19843324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry.
    Min SK; Choi SW; Lim J; Park JY; Jung KW; Won YJ
    Oral Oncol; 2019 Aug; 95():16-28. PubMed ID: 31345385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
    Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
    Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.
    Lu D; Zhou X; Sun H; Zeng B; Fu J; Gong J; Liao G; Liang Y; Yang L
    Clin Oral Investig; 2023 Sep; 27(9):4897-4910. PubMed ID: 37540282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary lung malignancy following head and neck squamous cell carcinoma.
    Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
    Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.
    Brands MT; Smeekens EAJ; Takes RP; Kaanders JHAM; Verbeek ALM; Merkx MAW; Geurts SME
    Cancer Med; 2019 Sep; 8(12):5810-5819. PubMed ID: 31400079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
    Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L
    J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic features of multiple primary cancers with oral squamous cell carcinoma.
    Cai X; Zhang J; Jing F; Zhou X; Zhang H; Li T
    Arch Oral Biol; 2023 May; 149():105661. PubMed ID: 36857878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis.
    Rubió-Casadevall J; Galceran J; Ameijide A; Puigdemont M; Llauradó L; Marruecos J; Izquierdo A; Carulla M; Borràs JL; Marcos-Gragera R; Gumà J
    Clin Transl Oncol; 2021 Apr; 23(4):788-798. PubMed ID: 32815088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.